WallStreetZenWallStreetZen

NASDAQ: XGN
Exagen Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

XGN past revenue growth

How has XGN's revenue growth performed historically?
Company
15.33%
Industry
0.45%
Market
17.57%
XGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
XGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
XGN's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

XGN earnings and revenue history

Current Revenue
$52.5M
Current Earnings
-$23.7M
Current Profit Margin
-45.1%

XGN Return on Equity

Current Company
-80.3%
Current Industry
-24%
Current Market
188%
XGN's Return on Equity (-80.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when XGN announces earnings.

XGN Return on Assets

Current Company
-36.3%
Current Industry
6.7%
XGN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

XGN Return on Capital Employed

Current Company
-47.34%
Current Industry
11.6%
XGN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

XGN vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
XGN$52.55M-$18.21M-$23.69M+10.13%N/A
OCX$1.50M-$26.05M-$28.72M+61.80%N/A
DMTK$15.30M-$95.04M-$100.89M+44.33%N/A
MYNZ$895.48k-$24.62M-$26.30M+33.56%N/A
TTOO$7.19M-$42.53M-$50.08M-7.29%N/A
View Top Diagnostic & Research Stocks

XGN earnings dates

Next earnings date
May 13, 2024

Exagen Earnings & Revenue FAQ

What were XGN's earnings last quarter?

On Invalid Date, Exagen (NASDAQ: XGN) reported Q4 2023 earnings per share (EPS) of -$0.31, up 62.65% year over year. Total Exagen earnings for the quarter were -$5.57 million. In the same quarter last year, Exagen's earnings per share (EPS) was -$0.83.

If you're new to stock investing, here's how to buy Exagen stock.

What was XGN's earnings growth in the past year?

As of Q2 2024, Exagen's earnings has grown year over year. Exagen's earnings in the past year totalled -$23.69 million.

What is XGN's earnings date?

Exagen's earnings date is Invalid Date. Add XGN to your watchlist to be reminded of XGN's next earnings announcement.

What was XGN's revenue last quarter?

On Invalid Date, Exagen (NASDAQ: XGN) reported Q4 2023 revenue of $13.77 million up 7.23% year over year. In the same quarter last year, Exagen's revenue was $12.84 million.

What was XGN's revenue growth in the past year?

As of Q2 2024, Exagen's revenue has grown 15.33% year over year. This is 14.88 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 0.45%. Exagen's revenue in the past year totalled $52.55 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.